Clinic business

TripSitter.Clinic launches new –

TORONTO, June 3, 2022 /PRNewswire/ – TripSitter Clinic Ltd. (CSE: KETA) (FSE: UY0) (“TripSitter” or the “Company”), today announced the official launch of the TripSitter app, a simple and free app that makes it easier for users to access services from TripSitter Clinics.

TripSitter Clinic CEO Dr. Huber said, “We are thrilled to announce the launch of our new app which will provide users with a convenient platform for patients to connect with a physician and then be guided through their psychedelic healing journey with specially trained Tripsitters.

The app is available to users through Apple App store and the Google Play Store. The app features a compatibility assessment so patients are matched with Tripsitters who share common interests and personalities. The app offers secure telehealth and unlimited messaging between patients and their Tripsitter and also allows for scheduling, medication tracking and billing.

TripSitter Clinic currently operates in Alabama, Arizona, California , Colorado, Florida, Georgia, Illinois, Indiana, Iowa, Kansas, Kentucky, Maine, Michigan, Minnesota, Mississippi, Montana, Nebraska, New Hampshire, New York, North Dakota, Ohio, Oklahoma, Pennsylvania, Tennessee, Texas, Vermont, Virginia, Washington, West Virginia, Wisconsin, Wyoming with continuous expansion through United States over the next 6 months.


TripSitter Clinic LTD., through its wholly owned subsidiary TripSitter Clinic Corp, is at the forefront of two emerging sectors: telehealth and psychedelic medicine. The Company’s virtual advisory clinic, TripSitter.Clinic, is an internationally renowned SaaS platform that provides care, monitoring and coaching while connecting patients with licensed physicians in United States who can evaluate a prescribed psychedelic treatment program of low dose ketamine therapeutic drugs. TripSitter is not a primary care physician (PCP). TripSitter.Clinic requires prospective patients to provide a diagnosis of their PCP along with other health information to their chosen TripSitter physician during the initial intake process. When a patient is approved for treatment by their doctor, TripSitter.Clinic connects the patient with experts who also use the platform to consult and coordinate with the patient and their doctor. Learn more at


dr. John HuberCEO
[email protected]

The Canadian Securities Exchange has neither approved nor disapproved of the contents of this press release and accepts no responsibility for the adequacy or accuracy of this release.

Disclaimer for forward-looking information

This press release contains certain forward-looking statements and information (collectively, “forward-looking statements”) within the meaning of applicable Canadian securities laws. Use of any of the words “expect”, “anticipate”, “continue”, “estimate”, “goal”, “may”, “will”, “project”, “should”, “believe ”, “plan”, “intends” and similar expressions are intended to identify forward-looking information or statements. Forward-looking statements and information are based on certain key expectations and assumptions made by the Company. Although the Company believes that the expectations and assumptions on which such forward-looking statements and information are based are reasonable, undue reliance should not be placed on forward-looking statements and information as the Company cannot give any assurance that they will prove to be correct. . Because forward-looking statements and information relate to future events and conditions, they, by their very nature, involve inherent risks and uncertainties. Forward-looking information in this press release includes statements regarding the company’s general business plans, the telehealth industry and the company’s market position within it, as well as statements regarding the of the company’s ordinary shares on the CSE. Actual results could differ materially from those currently anticipated due to a number of factors and risks. Factors that could materially affect such forward-looking information are described in the risk factors in the Company’s final long form prospectus dated November 22, 2021and the related schedules, which are available on the Company’s profile on SEDAR Readers are cautioned that the above list of factors is not exhaustive. The forward-looking statements included in this press release are expressly qualified by this cautionary statement. The forward-looking statements and information contained in this press release are made as of the date hereof, and the Company undertakes no obligation to publicly update or revise any forward-looking statements or information, whether as a result of new information, future events or otherwise. , except as required by applicable law.

favicon.png?sn=TO78138&sd=2022-06-03 View original content to download multimedia:

SOURCE TripSitter Clinic Ltd.